GIANFALDONI, GIACOMO
 Distribuzione geografica
Continente #
NA - Nord America 617
EU - Europa 378
AS - Asia 96
AF - Africa 1
Continente sconosciuto - Info sul continente non disponibili 1
Totale 1.093
Nazione #
US - Stati Uniti d'America 617
PL - Polonia 134
IT - Italia 62
IE - Irlanda 55
SE - Svezia 49
CN - Cina 36
HK - Hong Kong 34
CH - Svizzera 28
JO - Giordania 16
RU - Federazione Russa 14
GB - Regno Unito 12
DE - Germania 9
UA - Ucraina 7
FI - Finlandia 5
IN - India 4
BE - Belgio 2
SG - Singapore 2
TR - Turchia 2
VN - Vietnam 2
EU - Europa 1
NL - Olanda 1
SD - Sudan 1
Totale 1.093
Città #
Warsaw 134
Fairfield 107
Ashburn 61
Chandler 60
Dublin 55
Seattle 45
Woodbridge 44
Houston 35
Cambridge 30
Wilmington 29
Hong Kong 27
Bern 26
Beijing 25
Altamura 22
Lawrence 22
New York 21
Ann Arbor 20
Moscow 14
Princeton 14
Buffalo 13
Kent 12
Medford 11
Boston 7
Florence 7
Rome 7
San Diego 7
Bremen 6
Shanghai 5
Hillsboro 4
Jacksonville 4
Boardman 3
Falls Church 3
Bari 2
Brussels 2
Dong Ket 2
Izmir 2
Kolkata 2
Los Angeles 2
Manchester 2
Siena 2
Southport 2
Sulmona 2
Vicopisano 2
Biassono 1
Bologna 1
Corato 1
Glasgow 1
Groningen 1
Hefei 1
Inverigo 1
Kharkov 1
Laurel 1
Norwalk 1
Phoenix 1
Poplar 1
Prato 1
Pune 1
Ravenna 1
Redwood City 1
Salerno 1
Shenyang 1
Singapore 1
Torquay 1
Torre Del Lago 1
Totale 923
Nome #
CD20 expression has no prognostic role in Philadelphia-negativeB-precursor acute lymphoblastic leukemia: new insights from the molecularstudy of minimal residual disease. 216
Multilineage dysplasia as assessed by immunophenotype has no impact on clinical-biological features and outcome of NPM1-mutated acute myeloid leukemia 97
Early reduction of WT1 transcripts during induction chemotherapy predicts for longer disease free and overall survival in acute myeloid leukemia. 95
Focal spleen lesions in visceral leishmaniasis, a neglected manifestation of a neglected disease: report of three cases and systematic review of literature 82
Lenograstim and filgrastim in the febrile neutropenia prophylaxis of hospitalized patients: efficacy and cost of the prophylaxis in a retrospective survey 80
Cytarabine and clofarabine after high-dose cytarabine in relapsed or refractory AML patients. 79
Randomized trial comparing standard vs sequential high-dose chemotherapy for inducing early CR in adult AML 77
CXCR4 expression accounts for clinical phenotype and outcome in acute myeloid leukemia. 71
THIRD GENERATION SEQUENCING OF NORMAL KARYOTYPE ACUTE MYELOID LEUKEMIA: IMPLICATIONS FOR PROGNOSIS 66
Early peripheral clearance of leukemia-associated immunophenotypes in AML: centralized analysis of a randomized trial 63
Early peripheral blast cell clearance predicts minimal residual disease status and refines disease prognosis in AML 60
AMELIORATE: early intensification in FLT3-mutated acute myeloid leukemia based on peripheral blast clearance – MYNERVA-GIMEMA AML1919 trial 41
Venetoclax-Based Regimens for Relapsed/Refractory Acute Myeloid Leukemia in a Real-Life Setting: A Retrospective Single-Center Experience 33
Effect of age and treatment on predictive value of measurable residual disease: implications for clinical management of adult patients with acute myeloid leukemia 28
Quick complete response achievement with venetoclax and azacitidine in a case of relapsed disseminated blastic plasmacytoid dendritic cell neoplasm 18
Totale 1.106
Categoria #
all - tutte 3.615
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.615


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201946 0 0 0 0 0 0 0 0 0 0 26 20
2019/2020252 14 18 5 16 31 28 30 30 30 25 18 7
2020/2021133 11 16 5 8 5 16 6 9 19 10 18 10
2021/2022101 6 7 9 2 3 6 4 12 3 2 19 28
2022/2023299 22 74 18 14 14 41 29 14 36 2 6 29
2023/2024170 4 9 13 14 21 39 3 35 4 13 15 0
Totale 1.106